drugset / Trial / NCT05056584
The Role of the Kidneys and Liver in the Elimination of Glucagon
Completed
48 enrolled
University Hospital, Gentofte, Copenhagen
The Novo Nordisk Foundation Center for Basic Metabolic Research · collab
Non-randomizedParallel-groupOpen-labelBasic science
Summary
The study aims to evaluate the kinetics and effect of glucagon in patients with chronic kidney disease and liver cirrhosis and matched healthy subjects, respectively.
Timeline
- Start
- 2020-08-01
- Primary completion
- 2023-03-28
- Completion
- 2023-03-28
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Glucagon | Peptide | — | — |